Abstract P2-04-27: Development & Validation of RSC4All: an Artificial Intelligence-driven Machine Learning Nomogram Enhanced with Synthetic Data to Predict RSClin® Results & Guide Adjuvant Treatment of Node-negative HR-positive/HER2-negative Early Breast Cancer
Flavia Jacobs(Fondazione IRCCS Istituto Nazionale dei Tumori), Alberto Zambelli, Monica Fornier(Cornell University), C. Benvenuti, Carlo Tondini(Ospedale Papa Giovanni XXIII), Matteo Della Porta(University of Milan), Mariangela Gaudio(Humanitas University), Emanuela Ferraro(University of Milan), Giuseppe Saltalamacchia, Evandro de Azambuja(Université Libre de Bruxelles), Elisa Agostinetto(Université Libre de Bruxelles), Riccardo Gerosa(Humanitas University), Rita De Santis, Armando Santoro(IRCCS Humanitas Research Hospital), Saverio D’Amico(Istituti di Ricovero e Cura a Carattere Scientifico)
Cited by 0
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients
|British Journal of Cancer|2007|957
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821
HER2-Low Breast Cancer: Pathological and Clinical Landscape
|Journal of Clinical Oncology|2020|801